Phase
Condition
Lupus
Collagen Vascular Diseases
Myositis
Treatment
Dazukibart
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants that completed a qualifying study through Week 52.
Exclusion
Exclusion Criteria:
Any medical or psychiatric condition including recent (within the past year) oractive suicidal ideation/behavior or laboratory abnormality that may increase therisk of study participation.
Previous administration with an investigational product (drug or vaccine) other thandazukibart in a qualifying study within 30 days (or as determined by the localrequirement) or 5 half-lives preceding baseline in this study (whichever is longer).
Current use of any prohibited concomitant medication(s).
Active bacterial, viral, fungal, mycobacterial or other infections.
Ongoing adverse event in a qualifying study or the participant has met safetymonitoring criteria in a qualifying study that have not resolved.
Investigator site staff or sponsor employees directly involved in the conduct of thestudy, site staff otherwise supervised by the investigator, and their respectivefamily members.
Study Design
Connect with a study center
Medical Center Artmed
Plovdiv, 4000
BulgariaSite Not Available
Beijing Peking Union Medical College Hospital
Beijing, Beijing 100730
ChinaActive - Recruiting
Rheumatology & Pulmonary Clinic
Beckley, West Virginia 25801
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.